Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0002050755-25-000015
Filing Date
2025-10-15
Accepted
2025-10-15 18:32:47
Documents
1
Period of Report
2025-10-10

Document Format Files

Seq Description Document Type Size
1 form4-10152025_101041.html 4  
1 form4-10152025_101041.xml 4 11170
  Complete submission text file 0002050755-25-000015.txt   13141
Mailing Address 179 STARR DRIVE EASTSOUND WA 98245
Business Address
Hoffman Reid (Reporting) CIK: 0001519339 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39979 | Film No.: 251396024

Mailing Address 500 BOYLSTON STREET SUITE 1350 BOSTON MA 02116
Business Address 500 BOYLSTON STREET SUITE 1350 BOSTON MA 02116 617-655-6580
Vor Biopharma Inc. (Issuer) CIK: 0001817229 (see all company filings)

EIN.: 811591163 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 101 MISSION STREET, SUITE 1000 SAN FRANCISCO CA 94105
Business Address 101 MISSION STREET, SUITE 1000 SAN FRANCISCO CA 94105 415-541-0200
Reprogrammed Interchange LLC (Reporting) CIK: 0002050755 (see all company filings)

State of Incorp.: CA | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-39979 | Film No.: 251396025